                         SEQUENCE LISTING

<110>  The Research Foundation for The State University of New 
       York
 
<120>  RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF

<130>  011520.01552

<150>  62/928,884
<151>  2019-10-31

<150>  63/027,235
<151>  2020-05-19

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  1

Asn Val Tyr Asp Asn Asn His Leu Ser 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  2

Leu Leu Ile Tyr Tyr Ala Ser Ala Leu Ala 
1               5                   10  


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  3

Leu Gly Ser Tyr Asp Cys Ser Ala Asp Cys Phe Ala 
1               5                   10          


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  4

Cys Thr Val Ser Gly Phe Thr Ile Ser Ser Tyr Asp Met 
1               5                   10              


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  5

Ala Ile Asp Ser Ser Gly Ser Ala His 
1               5                   


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  6

Trp Asn Ala Asn 
1               


<210>  7
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL chain

<400>  7

Met Asp Thr Arg Ala Pro Thr Gln Leu Leu Gly Leu Leu Leu Leu Trp 
1               5                   10                  15      


Leu Pro Gly Ala Thr Phe Ala Gln Val Leu Thr Gln Thr Ala Ser Pro 
            20                  25                  30          


Val Ser Ala Ala Val Gly Ser Thr Val Thr Ile Asn Cys Gln Ala Ser 
        35                  40                  45              


Gln Asn Val Tyr Asp Asn Asn His Leu Ser Trp Tyr Gln Gln Lys Arg 
    50                  55                  60                  


Gly Gln Pro Pro Lys Leu Leu Ile Tyr Tyr Ala Ser Ala Leu Ala Ser 
65                  70                  75                  80  


Gly Val Ser Ser Arg Phe Lys Gly Ser Gly Ser Gly Thr Gln Phe Thr 
                85                  90                  95      


Leu Thr Ile Asn Asp Val Gln Cys Asp Asp Ala Ala Thr Tyr Tyr Cys 
            100                 105                 110         


Leu Gly Ser Tyr Asp Cys Ser Ala Asp Cys Phe Ala Phe Gly Gly Gly 
        115                 120                 125             


Thr Glu Val Val Val 
    130             


<210>  8
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH chain

<400>  8

Met Glu Thr Gly Leu Arg Trp Leu Leu Leu Val Ala Val Leu Lys Gly 
1               5                   10                  15      


Val Gln Cys Gln Ser Val Lys Glu Ser Glu Gly Gly Leu Phe Lys Pro 
            20                  25                  30          


Thr Asp Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Thr Ile Ser 
        35                  40                  45              


Ser Tyr Asp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu 
    50                  55                  60                  


Trp Ile Gly Ala Ile Asp Ser Ser Gly Ser Ala His Tyr Ala Ser Trp 
65                  70                  75                  80  


Ala Arg Ser Arg Ser Thr Ile Thr Arg Asn Thr Asn Leu Asn Thr Val 
                85                  90                  95      


Thr Leu Lys Met Thr Ser Leu Thr Ala Ala Asp Thr Ala Thr Tyr Phe 
            100                 105                 110         


Cys Trp Asn Ala Asn Ile Trp Gly Pro Gly Thr Leu Val Thr Val Ser 
        115                 120                 125             


Ser 
    


